Literature DB >> 11896827

Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma.

Suzana Orsini Machado de Sousa1, Ricardo Alves Mesquita, Décio Santos Pinto, Silvio Gutkind.   

Abstract

BACKGROUND: Studies have addressed the relevance of c-Jun and c-Fos proteins in cancer development. In the present study, the expression of c-Jun and c-Fos, the major components of transcription factor activator protein (AP1), were evaluated to determine possible alterations to these factors in oral squamous cell carcinoma (OSCC).
METHODS: Fifteen cases of normal oral mucosa and 20 cases of OSCC were retrieved from the Archives of the Surgical Pathology Service at the University of São Paulo. The samples of normal oral mucosa or OSCC originated from different oral mucosal sites. Tissues were submitted for immunohistochemical analysis to detect c-Jun and c-Fos proteins. The OSCC was classified as well, intermediate or poorly differentiated.
RESULTS: The results showed that both c-Jun and c-Fos are expressed in normal oral mucosa and in OSCC. In normal mucosa, immunoreactivity for c-Jun was detected in the cytoplasm of the upper basal layers, while in OSCC, c-Jun was detected in the nuclei of the cells. C-Fos expression was observed in the nuclei of cells, both in normal mucosa and in OSCC, but its expression varied according to the cell layer in normal mucosa, and the differentiation of OSCC.
CONCLUSIONS: The nuclear expression of c-Jun in OSCC, in contrast to its cytoplasmic expression in normal oral mucosa, indicates that c-Jun may have a role in the development of oral cancer. In contrast, the absence of both c-Jun and c-Fos in poorly differentiated carcinoma might be useful in understanding the cell cycle events important in uncontrolled cell growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896827     DOI: 10.1046/j.0904-2512.2001.10012.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

2.  Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study.

Authors:  Ming-Yao Wu; Chu-Xiang Zhuang; Huan-Xing Yang; Ying-Rui Liang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model.

Authors:  Daisuke Kamide; Taku Yamashita; Koji Araki; Masayuki Tomifuji; Yuya Tanaka; Shingo Tanaka; Shunichi Shiozawa; Akihiro Shiotani
Journal:  Cancer Sci       Date:  2016-04-26       Impact factor: 6.716

4.  Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study.

Authors:  Hao Xu; Xin Jin; Yao Yuan; Peng Deng; Lu Jiang; Xin Zeng; Xiao-Song Li; Zhi-Yong Wang; Qian-Ming Chen
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

Review 5.  The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer.

Authors:  Daniela D'Arcangelo; Lavinia Tinaburri; Elena Dellambra
Journal:  Int J Mol Sci       Date:  2017-07-22       Impact factor: 5.923

6.  Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma

Authors:  Akhilesh Krishna; Madan Lal Brahma Bhatt; Vineeta Singh; Shraddha Singh; Pravin Kumar Gangwar; Uma Shankar Singh; Vijay Kumar; Divya Mehrotra
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

Review 7.  Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).

Authors:  Rui He; Suya Du; Tiantian Lei; Xiaofang Xie; Yi Wang
Journal:  Oncol Rep       Date:  2020-10-20       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.